Spectrum Effect Announces Boulder Ventures Investment And Welcomes Kishen Mangat To The Board Of Directors
December 5, 2023 – Kirkland, WA – Spectrum Effect® announced today the Boulder Ventures (BV) investment into Spectrum Effect and the appointment of Kishen Mangat to its Board of Directors.
Kishen Mangat is General Partner at Boulder Ventures (BV), where he leads the firm’s enterprise 5G investment strategy. Kishen previously served as the Cisco Systems VP/GM for Mobility and co-founded multiple startups, including BroadHop, Inc.
Read More
Colorado’s leading avalanche educator took itself to task to see what is — and isn’t — working
Billy Rankin remembers a time not long ago when someone asked his 20-person guide team at Irwin Lodge in Crested Butte how many friends they’d had die in avalanches.
Nearly everyone raised a hand for one friend, most kept it raised for two and Rankin left his hand up as the number soared to 10. Part of that was odds: Rankin has been a ski guide and avalanche course instructor for decades and lives in Crested Butte, which he said “has a pretty high tolerance for risk.” But it also shows how crushing the consequences of shaky decision-making in the backcountry can be, which is why Rankin encourages his students to study every active avalanche accident report published by the Colorado Avalanche Information Center in a given winter, looking for “the skull and crossbones, the red flags” that are always so much easier to see in retrospect than they are in the mountains.
Read More
Merc Mercure and the History of Ball Aerospace
CU Boulder and Ball Aerospace have been collaborating for decades to solve mysteries of the universe. That partnership was also the university’s first commercial spin-off and it greased the gears of an entrepreneurial engine that continues to power innovation within the university and far beyond.
Read More
Mineralys Therapeutics Announces JAMA Publication of Full Target-HTN Phase 2 Trial Results for Lorundrostat in Uncontrolled and Treatment-Resistant Hypertension
RADNOR, Pa., Sept. 10, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other diseases driven by abnormally elevated aldosterone, today announced that full results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and treatment-resistant hypertension (rHTN) were published in the Journal of the American Medical Association (JAMA)
Read More
PlayMetrics Partners With Blue Star Innovation Partners to Propel Growth
MORRISVILLE, N.C., August 23, 2023 (Newswire.com) - PlayMetrics, a leading provider of operations management software for youth sports organizations, today announced a partnership with Blue Star Innovation Partners ("BSIP"). The growth-focused investment firm, founded by serial entrepreneur Rob Wechsler and backed by Dallas Cowboys owner Jerry Jones, will take a significant ownership position in PlayMetrics.
Read More
Joe Lefkoff 1935-2023
This week we said goodbye to our favorite Southern Jew in the Mountain West and most subtly voracious eater of life, Joe Lefkoff. Joe loved people and things so fiercely and yet so quietly: he loved a fluffy matzah ball, Moe’s BBQ, and spending hours moving between the hot tub and the swimming pool reading and sunning. He loved John Le Carre, Stephen Sondheim, Scrabble, and a well-crafted dirty joke. He loved grilling the perfect steak, going to New York and London every year to see the new theater, and chasing a royal straight flush on poker nights with his favorite guys.
Read More
Mineralys Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
RADNOR, Pa., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone, today announced financial results for the quarter ending June 30, 2023, and provided a corporate update.
Read More
CU’s Marvin Caruthers awarded inaugural prize, $400K, for biotech work
Marvin Caruthers, a prestigious University of Colorado Boulder biotechnology professor and researcher, has been named the first winner of the Richard N. Merkin Prize in Biomedical Technology for his work in DNA synthesis. The award, which comes with a $400,000 prize, was created by the Merkin Family Foundation and is administered by the Broad Institute of the Massachusetts Institute of Technology and Harvard University.
Read More
Accenture Takes Stake In Generative AI Enabler Stardog
Global solution provider Accenture Wednesday unveiled an investment in Stardog, a developer of technology that develops knowledge graphs of data that can be used by generative AI for detailed searches.
Stardog is the developer of Stardog Enterprise Knowledge Graphs, a technology that combines data from multiple sources and makes it machine-understandable without changing the underlying data. The aim is to allow such data to be easily searched, and it is being touted as a way to improve searches using generative AI.
Read More